Lite Strategy LITS
NASDAQ LITS
$1.16 +0.01 (+0.87%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Change in Receivables (2021)

Updated

Lite Strategy (LITS) recorded Change in Receivables of -$10 million in fiscal Q2 2022 (quarter ended Dec 31, 2021).

Analysis

Lite Strategy (LITS) Change in Receivables (2021) Analysis & Trends

For FY2021 (ended Jun 30, 2021), Lite Strategy reported Change in Receivables of $4.72 million, up 101.3% from FY2020.

  • Across earlier fiscal years, Change in Receivables came in at $2.35 million in FY2020 and $199,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 1.35 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 1.37 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 333.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Lite Strategy 40.09 Mn 7.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -10.00 Mn
Sep 30, 2021 10.00 Mn
Jun 30, 2021 25.14 Mn
API Access

Lite Strategy Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=LITS&period=max&api_key=YOUR_API_KEY